In atherosclerosis, plaque builds in arteries behind the inner lining, or epithelium, in a process involving inflammation and immune reaction complications.

Microfluidic chips will contain artificial human coronary arteries for highly reproducible experiments with engineered HDL. Shown here are microvessel mimicking chips, which are very similar. The arterial chips are being developed for the new research.

Georgia Tech biomedical engineering researcher Tony Kim received the esteemed NIH Director's New Innovator Award for his proposal on high-throughput research to tackle new possible treatments for atherosclerosis.

A human-coronary-artery-on-a-chip will be used in Tony Kim's research shown here with magnified endothelial cells. Shown here are epithelial cells in a similar microvessel mimicking chip. The new arterial chips are currently being developed for the new research.

High-throughput production of protein nanoparticles, illustrated here, allows for highly reproducible experiments and also the productive standardized assembly of nanoparticles that may prove to be good drug candidates for clinical trials to treat atherosclerosis.